| scholarly article | Q13442814 |
| P50 | author | Leendert A Trouw | Q40406948 |
| Mieke van Essen | Q63987248 | ||
| P2093 | author name string | C van Kooten | |
| R Lubbers | |||
| P2860 | cites work | gamma-Interferon increases expression of class III complement genes C2 and factor B in human monocytes and in murine fibroblasts transfected with human C2 and factor B genes | Q69873172 |
| Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase | Q70246701 | ||
| The secretion of the third component of complement (C3) by human polymorphonuclear leucocytes from both normal and systemic lupus erythematosus cases | Q70525487 | ||
| Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis | Q71885453 | ||
| Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation | Q72169141 | ||
| IgA and IgG immune complexes increase human macrophage C3 biosynthesis | Q72238539 | ||
| Complement component C7. Assessment of in vivo synthesis after liver transplantation reveals that hepatocytes do not synthesize the majority of human C7 | Q72363605 | ||
| Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils | Q73287589 | ||
| Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease | Q73664136 | ||
| Maturation of dendritic cells abrogates C1q production in vivo and in vitro | Q75272880 | ||
| Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies | Q78127364 | ||
| Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis | Q78833492 | ||
| Dendritic cells in the arterial wall express C1q: potential significance in atherogenesis | Q79106760 | ||
| Complement alternative pathway acts as a positive feedback amplification of neutrophil activation | Q82382595 | ||
| Complement--tapping into new sites and effector systems | Q85959086 | ||
| Expression and regulation of complement receptors by human natural killer cells | Q87771669 | ||
| rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues | Q22009921 | ||
| Identification of human CD93 as the phagocytic C1q receptor (C1qRp) by expression cloning | Q24292115 | ||
| Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue | Q24292702 | ||
| Human C1qRp is identical with CD93 and the mNI-11 antigen but does not bind C1q | Q24296794 | ||
| CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens | Q24307492 | ||
| Effect of interferon-gamma on complement gene expression in different cell types | Q24527334 | ||
| The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytes | Q24653022 | ||
| Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway | Q26768534 | ||
| Complement regulation of T cell immunity | Q26827470 | ||
| A crystal structure of the complex between human complement receptor 2 and its ligand C3d | Q27667612 | ||
| Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3 | Q27680051 | ||
| C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway | Q28116293 | ||
| Structure of C3b in complex with CRIg gives insights into regulation of complement activation | Q28269302 | ||
| C3d of complement as a molecular adjuvant: bridging innate and acquired immunity | Q28272810 | ||
| Complement receptors in neutrophils | Q28273972 | ||
| Biosynthesis of the first component of complement by human and guinea pig peritoneal macrophages: evidence for an independent production of the C1 subunits | Q28276981 | ||
| Human M-ficolin is a secretory protein that activates the lectin complement pathway | Q28610924 | ||
| Complement: a key system for immune surveillance and homeostasis | Q29615484 | ||
| Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans | Q30449886 | ||
| Complement regulators and inhibitory proteins | Q33386110 | ||
| Of mice and men: The factor H protein family and complement regulation. | Q33421580 | ||
| Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells | Q33570304 | ||
| The role of complement in the acquired immune response | Q33917858 | ||
| C1q receptors. | Q33938158 | ||
| Regulation of the synthesis of C1 subcomponents and C1-inhibitor | Q34340423 | ||
| Immune cell-derived C3a and C5a costimulate human T cell alloimmunity. | Q34370940 | ||
| Complement System Part I - Molecular Mechanisms of Activation and Regulation | Q34481071 | ||
| Human complement receptors for C3b (CR1) and C3d (CR2). | Q34564402 | ||
| Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells | Q34760201 | ||
| Complement Receptor 1: disease associations and therapeutic implications. | Q34878497 | ||
| Expression of complement components, receptors and regulators by human dendritic cells. | Q34885229 | ||
| Molecular basis for complement recognition by integrin αXβ2. | Q35849584 | ||
| Complement C3dg-mediated erythrophagocytosis: implications for paroxysmal nocturnal hemoglobinuria. | Q35953532 | ||
| C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. Comparison with secretion of interleukin 1 beta and interleukin 1 alpha | Q36355106 | ||
| Decay-accelerating factor modulates induction of T cell immunity | Q36403001 | ||
| Local release of properdin in the cellular microenvironment: role in pattern recognition and amplification of the alternative pathway of complement. | Q36540594 | ||
| C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation | Q36541076 | ||
| Complement biosynthesis by the human hepatoma-derived cell line HepG2 | Q36987205 | ||
| Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection | Q37106399 | ||
| T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. | Q37241002 | ||
| A role of macrophage complement receptor CRIg in immune clearance and inflammation. | Q37254633 | ||
| Complement production and regulation by dendritic cells: molecular switches between tolerance and immunity | Q37300233 | ||
| Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation | Q37397572 | ||
| The non-classical functions of the classical complement pathway recognition subcomponent C1q. | Q37728390 | ||
| The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: review | Q38026309 | ||
| The role of complement in CD4⁺ T cell homeostasis and effector functions | Q38110968 | ||
| Complement deficiencies in systemic lupus erythematosus | Q38210887 | ||
| Complement, c1q, and c1q-related molecules regulate macrophage polarization | Q38246272 | ||
| C1q, antibodies and anti-C1q autoantibodies. | Q38511260 | ||
| Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense | Q38558926 | ||
| A journey through the lectin pathway of complement-MBL and beyond | Q38558930 | ||
| Complement C3 is expressed by mast cells in cutaneous vasculitis and is degraded by chymase | Q38755354 | ||
| The complement and contact activation systems: partnership in pathogenesis beyond angioedema | Q38991081 | ||
| High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques | Q39193960 | ||
| The production and secretion of complement component C1q by human mast cells | Q39371149 | ||
| Levels of lectin pathway proteins in plasma and synovial fluid of rheumatoid arthritis and osteoarthritis | Q39764375 | ||
| Synthesis of complement by macrophages and modulation of their functions through complement activation | Q40169178 | ||
| NETosing Neutrophils Activate Complement Both on Their Own NETs and Bacteria via Alternative and Non-alternative Pathways | Q40171437 | ||
| Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes. | Q40187096 | ||
| Structure, function and cellular expression of complement anaphylatoxin receptors | Q40540064 | ||
| Mucosal type mast cells express complement receptor type 2 (CD21). | Q40732437 | ||
| Molecular assembly of CD46 with CD9, alpha3-beta1 integrin and protein tyrosine phosphatase SHP-1 in human macrophages through differentiation by GM-CSF. | Q40749141 | ||
| Properdin: approaching four decades of research | Q40804724 | ||
| Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation | Q40875377 | ||
| CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions | Q40903321 | ||
| The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. | Q41052853 | ||
| Biosynthesis and secretion of complement component (C3) by activated human polymorphonuclear leukocytes | Q41108317 | ||
| Complement receptor type 1 (CR1/CD35) expressed on activated human CD4+ T cells contributes to generation of regulatory T cells | Q41288623 | ||
| Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. | Q41294733 | ||
| Extrahepatic complement biosynthesis: where, when and why? | Q41331539 | ||
| Modified low density lipoprotein stimulates complement C3 expression and secretion via liver X receptor and Toll-like receptor 4 activation in human macrophages. | Q41482082 | ||
| Expression of properdin in human monocytes | Q41491340 | ||
| Properdin, a positive regulator of complement activation, is expressed in human T cell lines and peripheral blood T cells | Q41529943 | ||
| Complement factors H and I synthesized by B cell lines function to generate a growth factor activity from C3. | Q41555822 | ||
| Detection of properdin mRNA in human peripheral blood monocytes and spleen | Q41595530 | ||
| Synthesis of complement component C5 by human B and T lymphoblastoid cell lines | Q41756353 | ||
| Biosynthesis in vitro of complement subcomponents C1q, C1s and C1̅ inhibitor by resting and stimulated human monocytes | Q41843990 | ||
| Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes | Q41894352 | ||
| Complement-subcomponent-C1-inhibitor synthesis by human monocytes | Q41917355 | ||
| Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. | Q41940468 | ||
| Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. | Q42425832 | ||
| Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes | Q42859242 | ||
| Integrin CD11c/CD18 α-chain phosphorylation is functionally important. | Q42905780 | ||
| Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation. | Q43630649 | ||
| Human skin mast cells express complement factors C3 and C5. | Q44986589 | ||
| Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. | Q45966283 | ||
| Isolation and characterization of macrophage-derived C1q and its similarities to serum C1q. | Q46192544 | ||
| CR3 is the dominant phagocytotic complement receptor on human dendritic cells. | Q47242705 | ||
| Human C′3: Evidence for the Liver as the Primary Site of Synthesis | Q47802638 | ||
| Levels of expression of complement regulatory proteins CD46, CD55 and CD59 on resting and activated human peripheral blood leucocytes | Q50335848 | ||
| Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages. | Q53958725 | ||
| Human monocyte-derived dendritic cells are a source of several complement proteins. | Q54593034 | ||
| Organ-specific contribution to circulating C7 levels by the bone marrow and liver in humans | Q57089607 | ||
| Extrahepatic secreted complement C3 contributes to circulating C3 levels in humans | Q57089621 | ||
| Complement components, regulators and receptors are produced by human monocyte-derived dendritic cells. | Q64890884 | ||
| Synthesis of complement components C5, C6, C7, C8 and C9 in vitro by human monocytes and assembly of the terminal complement complex | Q69629002 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 183-194 | |
| P577 | publication date | 2017-03-24 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Production of complement components by cells of the immune system | |
| P478 | volume | 188 |
| Q47112394 | Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis |
| Q59791600 | Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population |
| Q56983888 | An Integrated, High-Throughput Strategy for Multiomic Systems Level Analysis |
| Q91802539 | Anti-Bacterial Effect of CpG-DNA Involves Enhancement of the Complement Systems |
| Q60919605 | Both Intrinsically Disordered Regions and Structural Domains Evolve Rapidly in Immune-Related Mammalian Proteins |
| Q99710887 | Cell type specific gene expression profiling reveals a role for complement component C3 in neutrophil responses to tissue damage |
| Q100634927 | Cell-free DNA in plasma as an essential immune system regulator |
| Q89453519 | Characterizing a pH-switch anti-C5 antibody as a tool for human and mouse complement C5 purification and cross-species inhibition of classical and reactive lysis |
| Q92185716 | Cigarette smoke-induced reduction of C1q promotes emphysema |
| Q57300387 | Comparative Proteomic Analysis of Two Differently Extracted Coptis chinensis in the Treatment of Type 2 Diabetic Rats |
| Q89820633 | Complement Activation Is Associated With Mortality in Patients With Necrotizing Soft-Tissue Infections-A Prospective Observational Study |
| Q58572640 | Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis |
| Q64069996 | Complement Evasion: An Effective Strategy That Parasites Utilize to Survive in the Host |
| Q91938971 | Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses |
| Q92876720 | Complement alone drives efficacy of a chimeric antigonococcal monoclonal antibody |
| Q83228071 | Complement and CD4 T cells drive context-specific corneal sensory neuropathy |
| Q57492005 | Complement as a Biological Tool to Control Tumor Growth |
| Q40986583 | Complement in Non-Antibody-Mediated Kidney Diseases. |
| Q50049007 | Complement in cancer: untangling an intricate relationship. |
| Q90149942 | Complement proteins in unexpected places: why we should be excited, not concerned! |
| Q64988295 | Complementing Cancer Metastasis. |
| Q64118822 | Complementing the Cancer-Immunity Cycle |
| Q92259913 | Complex medical history of a patient with a compound heterozygous mutation in C1QC |
| Q91013849 | Context-dependent roles of complement in cancer |
| Q52659567 | Contribution of Adipose-Derived Factor D/Adipsin to Complement Alternative Pathway Activation: Lessons from Lipodystrophy. |
| Q59132967 | Cutaneous Vasculitis and Digital Ischaemia Caused by Heterozygous Gain-of-Function Mutation in |
| Q92238529 | Development and characterization of novel anti-C5 monoclonal antibodies capable of inhibiting complement in multiple species |
| Q90429488 | Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells |
| Q64094349 | Evaluation of the Ability of Immune Humanized Mice to Demonstrate CD20-Specific Cytotoxicity Induced by Ofatumumab |
| Q49372307 | Francisella tularensis Confronts the Complement System |
| Q92756178 | Functional Characterization of Secreted Aspartyl Proteases in Candida parapsilosis |
| Q64275574 | High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway |
| Q124962443 | Immune damage in Long Covid |
| Q91338611 | Immunomodulation by testosterone and corticosterone in toads: Experimental evidences from transdermal application |
| Q94464397 | Innate and Adaptive Immune Responses in HELLP Syndrome |
| Q90265983 | Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b |
| Q90623554 | Interferon-complement loop in transplant-associated thrombotic microangiopathy |
| Q57110582 | Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients |
| Q91776030 | Landscape of innate immune system transcriptome and acute T cell-mediated rejection of human kidney allografts |
| Q98159712 | Linking Complement C3 and B Cells in Nasal Polyposis |
| Q63916938 | New tricks for an ancient system: Physiological and pathological roles of complement in the CNS |
| Q64076539 | Oral Vaccination With a Formulation Combining Subolesin With Heat Inactivated Reduces Tick Infestations in Cattle |
| Q58616776 | PD-1 immunobiology in systemic lupus erythematosus |
| Q47142811 | Plasma complement component 4 increases in patients with major depressive disorder |
| Q55686538 | Platinum Nanoparticles Decrease Reactive Oxygen Species and Modulate Gene Expression without Alteration of Immune Responses in THP-1 Monocytes. |
| Q90074220 | Proteomics-Based Detection of Immune Dysfunction in an Elite Adventure Athlete Trekking Across the Antarctica |
| Q58111137 | Role of the Complement System in the Response to Orthopedic Biomaterials |
| Q92229355 | Sarcodia suieae acetyl-xylogalactan regulate RAW 264.7 macrophage NF-kappa B activation and IL-1 beta cytokine production in macrophage polarization |
| Q89731499 | Serum immunoglobulin G4 in Sjögren's syndrome: a pilot study |
| Q52319498 | Skeletal muscle regeneration is modulated by inflammation. |
| Q91892624 | Systemic and pulmonary C1q as biomarker of progressive disease in experimental non-human primate tuberculosis |
| Q49898514 | Targeting complement-mediated immunoregulation for cancer immunotherapy |
| Q55000917 | The Lectin Complement Pathway Is Involved in Protection Against Enteroaggregative Escherichia coli Infection. |
| Q92670282 | The Sleep-Immune Crosstalk in Health and Disease |
| Q90813046 | The complement cascade in Alzheimer's disease: a systematic review and meta-analysis |
| Q50021113 | The complement system in the airway epithelium - an overlooked host defense mechanism and therapeutic target? |
| Q52724552 | The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis. |
| Q64067670 | Therapeutic Inhibition of the Complement System in Diseases of the Central Nervous System |
| Q90430030 | Thrombin and Plasmin Alter the Proteome of Neutrophil Extracellular Traps |
| Q92650824 | Transcription Profiling of Monocyte-Derived Macrophages Infected In Vitro With Two Strains of Streptococcus agalactiae Reveals Candidate Pathways Affecting Subclinical Mastitis in Cattle |
| Q47137448 | Transcriptome analysis of ruminal epithelia revealed potential regulatory mechanisms involved in host adaptation to gradual high fermentable dietary transition in beef cattle |
| Q98177720 | Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics |
Search more.